Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma

Volume: 8, Issue: 63, Pages: 107096 - 107108
Published: Nov 6, 2017
Abstract
// Maria Kissel 1 , Sandra Berndt 2 , Lukas Fiebig 1 , Simon Kling 3 , Qunsheng Ji 4 , Qingyang Gu 4 , Tina Lang 5 , Frank-Thorsten Hafner 1 , Michael Teufel 6 and Dieter Zopf 2 1 Drug Discovery, Bayer AG, Wuppertal, Germany 2 Drug Discovery, Bayer AG, Berlin, Germany 3 Biochemistry, NMI Natural and Medicinal Sciences Institute, University of Tübingen, Reutlingen, Germany 4 Research Service Division, Oncology & Immunology Unit, WuXi...
Paper Details
Title
Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma
Published Date
Nov 6, 2017
Journal
Volume
8
Issue
63
Pages
107096 - 107108
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.